T
KERX

TradeWorx’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

TradeWorx’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-30,660
Closed -$397K – 610
2013
Q4 		$397K Buy
+30,660
New +$366K 0.17% 207

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

TradeWorx's KERX Position: Q1 2014 in Review

TradeWorx sold out of Keryx Biopharmaceuticals Inc (KERX) in Q1 2014, closing a stake of 30,660 shares — an estimated $397K sold.

TradeWorx first reported a position in KERX in Q4 2013 and held it in 1 quarter. The position peaked at $397K in Q4 2013. 150 funds tracked by Wall St. Rank hold KERX as of Q1 2014.

  • TradeWorx reported no remaining Keryx Biopharmaceuticals Inc position as of Q1 2014 after selling out during the quarter.
  • TradeWorx sold 30,660 Keryx Biopharmaceuticals Inc shares in Q1 2014, an estimated $397K.
  • TradeWorx first reported a position in Keryx Biopharmaceuticals Inc in Q4 2013 and held it in 1 quarter.
  • TradeWorx's Keryx Biopharmaceuticals Inc position peaked at $397K in Q4 2013.
  • 150 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q1 2014.

Based on TradeWorx's 13F filing for Q1 2014, filed 2 Jun 2014.